DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Gujarat Themis Biosyn Limited — Outcome of Board Meeting

NSE 1 hr ago·7 Aug 2026, 7:42 am

Gujarat Themis Biosyn

Gujarat Themis Biosyn Limited has announced its unaudited financial results for the period ending June 30, 2026. The company has submitted these standalone and consolidated results to the stock exchange, providing an interim update on its financial performance.

For investors, this disclosure offers a preliminary look at the company's operational health and financial trajectory during the first half of the fiscal year. It helps in assessing the company's current momentum against its peers and market expectations.

Investors should monitor the detailed financial statements released alongside this announcement to analyze key metrics such as revenue growth, profit margins, and cash flow. This data will be crucial for evaluating the company's performance in the coming months.